Back

Improved prognosis prediction of idiopathic pulmonary arterial hypertension using targeted plasma proteomics in disease management

31 August 2024 (16:00 - 16:50)
Organised by: Logo
Congress Presentation Part of: Molecular modifiers of pulmonary vascular disease Pulmonary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Yicheng Yang

State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular D, Beijing (China)

7 More presentations in this session

Presentation thumbnail
CILP1 and NTproBNP in pulmonary hypertension and right ventricular pressure overload: a translational experimental study
Doctor A. Garcia-Alvarez (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Recruitment of CCR5-positive T cells in pulmonary vascular lesions in idiopathic- and connective tissue disease associated- pulmonary arterial hypertension
Doctor K. Ohta-Ogo (Suita, JP)
Abstract Slides Video
Presentation thumbnail
Comprehensive bioinformatic analysis identified m6A methylation as an important regulator in mediating immune response during idiopathic pulmonary arterial hypertension
Doctor N. Liu (Changsha, CN)
Abstract Slides Video
Presentation thumbnail
Ambrisentan reverses the prosenescent and anti-autophagic effect of high glucose on human pulmonary artery endothelial cells exposed to hypoxia
Doctor F. Biondi (IT)
Abstract Slides Video
Presentation thumbnail
PEDF upregulated in Ngfr-positive cells suppresses proliferation of pulmonary artery smooth muscle cells
Doctor C. Goten (Kanazawa, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular modifiers of pulmonary vascular disease

The Event

Event poster

ESC Congress 2024

31 August 2024 16:00 CET
You may be interested in
thumbnail
Congress Presentation
A single echocardiographic or hemodynamic parameter improves risk stratification in prevalent patients with pulmonary arterial hypertension
thumbnail
Congress Presentation
Metabolomics for prognostic stratification in pulmonary hypertension patients
thumbnail
Congress Presentation
Will omics finally fulfil the promise of personalised medicine in pulmonary hypertension?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources